Trial Profile
To study the effect Of saroglitazar on insulin sensitivity in patients with type 2 diabetes mellitus
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Jan 2018
Price :
$35
*
At a glance
- Drugs Saroglitazar (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Jan 2018 New trial record